Ignite Creation Date:
2024-05-05 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 9:57 AM
Study NCT ID:
NCT00779779
Status:
COMPLETED
Last Update Posted:
2018-08-28
First Post:
2008-10-23
Brief Title:
Evaluation of Reactogenicity and Safety of GSK Biologicals Rotarix Human Rotavirus Vaccine in Infants
Sponsor:
Organization:
GlaxoSmithKline
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
None
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: